1. Which of the following best describes the rates of anemia in women and men, according to NHANES data?
A. Anemia rates are approximately 50% higher in adult women of childbearing age, compared with rates in men of the same ages.
B. For women in their 20s and 30s, anemia rates are between 7 and 9 times higher than anemia rates in men of the same ages.
C. Rates of anemia are about the same among males and females up to age 20, then rates begin to climb in women due to postpartum anemia
D. Anemia rates are higher in women compared with men at every age range
2. Data from NHANES on racial differences in anemia rates show:
A. Approximately equivalent rates among black and white women
B. Approximately equivalent rates among black and Hispanic women
C. More than double the rate among black women versus white
D. More than triple the rate among black women versus white
3. Reasons for higher rates of anemia among women include:
A. lower dietary iron intake among women
B. higher metabolic demands for iron among women
C. blood loss from menstruation
D. higher rates of chronic diseases such as CKD
4. The hemoglobin threshold that indicates anemia in non-pregnant women over age 15 is:
A. <13 g/dL
B. <12 g/dL
C. <11 g/dL
D. <10 g/dL
5. The Centers for Disease Control and Prevention (CDC) recommend evaluating hemoglobin and ferritin in pregnant women at which of the following intervals?
A. First prenatal visit and early in third trimester
B. Early in the second trimester
C. Monthly
D. No routine screening
6. When oral iron therapy is initiated for treatment of anemia, what is the recommended elemental iron daily dose?
A. 30 mg
B. 50 mg
C. 60–120 mg
D. 120–200 mg
7. A patient in the pharmacy is picking up a prescription for prenatal vitamins and asks if it is safe for her to continue taking an oral iron tablet. An appropriate response would be:
A. Prenatal vitamins contain iron, so the patient should not continue with the iron supplement
B. Prenatal vitamins rarely contain iron, so it is important that the patient continues with her oral iron tablet
C. The prenatal vitamin should be checked to determine its iron dosage, if present
D. The prenatal vitamin should be substituted for one that contains iron
8. Among the following IV iron formulations, the risk of hypersensitivity reaction is highest with:
A. Ferric carboxymaltose
B. Ferumoxytol
C. Iron dextran
D. Iron sucrose
9. Which of the following agents may have reduced absorption when co-administered with iron?
A. H2 receptor blockers
B. Calcium
C. Vitamin C
D. Levothyroxine
10. Which of the following patients is the best candidate for IV iron?
A. 34-year-old woman who is vegetarian and Hgb 12 g/dL
B. 27-year-old woman in the second trimester of pregnancy with Hgb of 9 g/dL
C. 55-year-old African-American male with diabetes and Hgb of 13 g/dL
D. 44-year-old Hispanic woman with heavy menstrual periods and a recent Hgb of 11 g/dL
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
